CELEX: 32014M7346
Language: en
Date: 2014-09-12 00:00:00
Title: Commission Decision of 12/09/2014 declaring a concentration to be compatible with the common market (Case No COMP/M.7346 - MONTAGU FUNDS / ASTORG FUNDS / DIACINE FRANCE) according to Council Regulation (EC) No 139/2004 (Only the English text is authentic)

|[pic]                             |EUROPEAN COMMISSION                                                                                      |
|                                  |                                                                                                         |
|                                  |                                                                                                         |
|                                  |                                                                                                         |
|                                  |                                                                                                         |

                                        Brussels, 12.9.2014
                                        C(2014) 6539 final

                                        |To the notifying parties:                                          |                                                                   |

Dear Madam(s) and/or Sir(s),

Subject:    Case M.7346 - MONTAGU FUNDS / ASTORG FUNDS / DIACINE FRANCE
         Commission decision pursuant to Article 6(1)(b) of Council Regulation (EC) No 139/2004[1]

 1. On 19 August 2014, the Commission received a notification of a proposed concentration pursuant to Article 4 of  Council  Regulation  (EC)  No
    139/2004 by which Montagu funds and Astorg funds respectively  managed  and  controlled  by  the  undertakings  Montagu  Private  Equity  SAS
    (“Montagu”, France), controlled by Montagu Private Equity LLP (United Kingdom), and Astorg Partners SAS (“Astorg”, France) acquire within the
    meaning of Article 3(1)(b) of the Merger Regulation joint control of Diacine France SAS (“Diacine France”, France), by  way  of  purchase  of
    shares and securities.

 2. The business activities of the undertakings concerned are the following:

    - Montagu: French fund manager controlling several companies active within a broad range of industry  sectors,  including  notably  used  car
    valuation, manufacture of margarine, healthcare and education.

    - Astorg: Independent private equity firm incorporated under French law, which manages funds investing in a broad range of  industries,  such
    as healthcare, the manufacturing of glass bottles, cements or insurance brokerage.

    - Diacine France: Holding company of Sebia SA, an in vitro diagnostics specialty company  developing  innovative  diagnostics  solutions  for
    biologists and physicians in the fields of oncology, haemoglobin disorders and other metabolic disorders including diabetes[2].

 3. After examination of the notification, the European Commission has concluded that the notified operation falls within the scope of the Merger
    Regulation and of paragraph 5(c) of the Commission Notice on a simplified procedure for treatment of  certain  concentrations  under  Council
    Regulation (EC) No 139/2004[3].

 4. For the reasons set out in the Notice on a simplified procedure, the European Commission has decided not to oppose the notified operation and
    to declare it compatible with the internal market and with the EEA Agreement. This decision is adopted in application of Article  6(1)(b)  of
    the Merger Regulation.

                                        For the Commission

                                        (signed)
                                        Alexander ITALIANER
                                        Director General
-----------------------
[1]   OJ L 24, 29.1.2004, p. 1 ("the Merger Regulation"). With effect from 1 December 2009, the Treaty on the Functioning of the  European  Union
      ("TFEU") has introduced certain changes, such as the replacement of "Community" by "Union" and "common market" by  "internal  market".  The
      terminology of the TFEU will be used throughout this decision.
[2]   Publication in the Official Journal of the European Union No C 287, 28.08.2017, p. 3.
[3]   OJ C 366, 14.12.2013, p. 5.

-----------------------
                                                                  PUBLIC VERSION

                                                           SIMPLIFIED MERGER PROCEDURE